After a year of living with the realities of a “Covid-19 world,” a new administration and new regulatory measures on the horizon, many in the life sciences industry want to understand their impact and gain insight into what’s next on the commercial and regulatory fronts. Mike Townsend, Research Director for IDC’s Commercial Life Sciences Strategy practice, will offer his thoughts on the key trends he sees across pharmaceutical, biotech and medical device manufacturing industries for 2021 and beyond.

What you’ll learn:

• Key trends impacting life sciences and regulatory changes to expect in 2021 and beyond
• An update on latest technologies to watch, like AI, RPA, and blockchain
• Perspectives on pharmaceutical, biopharma, and medical technology industries